Vivace Therapeutics’ $35 Million Series D Financing Round

Cooley advised Vivace Therapeutics, Inc., and Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics on the patent matters related to the transaction.Vivace Therapeutics, Inc. announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here